Scientists at Bar-Ilan University in Israel successfully targeted and rendered inert the enzyme that metastatic cancer cells need to survive in the body once they have left their host tumor. ...
Triple Negative Breast Cancer – What Every Patient Should Know
Nearly 15-20% of breast cancers are so-called “triple negative,” meaning such cancers have tested negative in pathology reports for estrogen receptors, progesterone receptors, and Her2/Neu. The growth of these cancers are not fueled by estrogen and progesterone, as are most cancers, and therefore, do not respond to hormonal therapies such as…...
Strategic Media Partner
